Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

B SINGAPORE and TAIPEI, April 30, 2026 /PRNewswire/ — Formosa Pharmaceuticals, Inc. (“Formosa”, 6838.TW) and the Singapore Eye Research Institute (“SERI”) are pleased to announce…
posteditor
posteditor
Articles: 17424

Other News